Wang Xunjiang, Zhao Hanyang, Lin Wenyuan, Fan Wenxiang, Zhuang Tongxi, Wang Xu, Li Qi, Wei Xiaohui, Wang Zhengtao, Chen Kaixian, Yang Li, Ding Lili
Shanghai Key Laboratory of Complex Prescription, and Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines and the State Administration of Traditional Chinese Medicine (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Shanghai R&D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, PR China.
Shanghai Key Laboratory of Complex Prescription, and Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines and the State Administration of Traditional Chinese Medicine (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China.
Phytomedicine. 2025 Apr;139:156513. doi: 10.1016/j.phymed.2025.156513. Epub 2025 Feb 13.
Acute lung injury (ALI) is a severe inflammatory condition characterized by dysregulated immune responses and high mortality rates, with limited effective therapeutic options currently available. Panax notoginseng saponins (PNS), bioactive compounds derived from Panax notoginseng, have shown promise in mitigating lipopolysaccharide (LPS)-induced ALI. However, the molecular mechanisms underlying their therapeutic effects remain poorly understood. Given the critical role of M2-like macrophage polarization in resolving inflammation and promoting tissue repair, we investigated whether PNS exerts its protective effects in ALI by modulating this process. Furthermore, we explored the specific involvement of the signal transducer and activator of transcription 6 (STAT6) pathway in mediating these effects.
Chemical profiling of PNS was performed using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS), followed by quantitative analysis of its major bioactive components via high-performance liquid chromatography (HPLC). To evaluate the therapeutic efficacy of PNS and its principal constituents, we established an ALI mouse model through intratracheal administration of LPS. Comprehensive assessments included lung field shadowing, oxygen saturation levels, pulmonary function, and systematic histopathological examination. The regulatory effects of PNS on macrophage polarization were examined in THP-1 cells and bone marrow-derived macrophages (BMDMs), with cellular phenotypes analyzed by flow cytometry. To elucidate the mechanistic role of STAT6 in PNS-mediated protection, experiments were conducted using Stat6-deficient BMDMs and Stat6 knockout mice.
UPLC-Q-TOF-MS and HPLC identified and quantified the principal components of PNS: Notoginsenoside R1, Ginsenoside Rg, Ginsenoside Re, and Ginsenoside Rb. PNS treatment dose-dependently reduced inflammatory responses in LPS-induced ALI mice, as evidenced by decreased cytokine levels. Each of the four major PNS components independently alleviated ALI symptoms in mice. Pathway analysis revealed 56 potential ALI-related targets, with Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment suggesting that PNS exerts its protective effects by modulating inflammatory signaling pathways. In vitro studies demonstrated that PNS promoted STAT6 phosphorylation and nuclear translocation, enhancing M2-like macrophage polarization and interleukin-10 (IL-10) secretion in a STAT6-dependent manner. Genetic ablation of Stat6 partially reversed the protective effects of PNS on ALI, macrophage polarization, and IL-10 production, confirming the pivotal role of STAT6 in mediating PNS activity.
This study demonstrates that PNS alleviates LPS-induced ALI by promoting STAT6-dependent M2-like macrophage polarization, highlighting its potential as a therapeutic agent for ALI. These findings provide mechanistic insights into the anti-inflammatory actions of PNS and underscore the importance of STAT6 signaling in its protective effects.
急性肺损伤(ALI)是一种严重的炎症性疾病,其特征为免疫反应失调且死亡率高,目前有效的治疗选择有限。三七皂苷(PNS)是从三七中提取的生物活性化合物,已显示出减轻脂多糖(LPS)诱导的ALI的潜力。然而,其治疗作用的分子机制仍知之甚少。鉴于M2样巨噬细胞极化在解决炎症和促进组织修复中的关键作用,我们研究了PNS是否通过调节这一过程在ALI中发挥保护作用。此外,我们探讨了信号转导和转录激活因子6(STAT6)通路在介导这些作用中的具体参与情况。
使用超高效液相色谱-四极杆飞行时间质谱(UPLC-Q-TOF-MS)对PNS进行化学分析,随后通过高效液相色谱(HPLC)对其主要生物活性成分进行定量分析。为了评估PNS及其主要成分的治疗效果,我们通过气管内注射LPS建立了ALI小鼠模型。综合评估包括肺野阴影、血氧饱和度水平、肺功能和系统组织病理学检查。在THP-1细胞和骨髓来源的巨噬细胞(BMDM)中检测PNS对巨噬细胞极化的调节作用,通过流式细胞术分析细胞表型。为了阐明STAT6在PNS介导的保护中的机制作用,使用Stat6缺陷的BMDM和Stat6基因敲除小鼠进行实验。
UPLC-Q-TOF-MS和HPLC鉴定并定量了PNS的主要成分:三七皂苷R1、人参皂苷Rg、人参皂苷Re和人参皂苷Rb。PNS治疗剂量依赖性地降低了LPS诱导的ALI小鼠的炎症反应,细胞因子水平降低证明了这一点。PNS的四种主要成分各自独立减轻了小鼠的ALI症状。通路分析揭示了56个潜在的ALI相关靶点,京都基因与基因组百科全书(KEGG)富集表明PNS通过调节炎症信号通路发挥其保护作用。体外研究表明,PNS促进STAT6磷酸化和核转位,以STAT6依赖的方式增强M2样巨噬细胞极化和白细胞介素-10(IL-10)分泌。Stat6基因敲除部分逆转了PNS对ALI、巨噬细胞极化和IL-10产生的保护作用,证实了STAT6在介导PNS活性中的关键作用。
本研究表明,PNS通过促进STAT6依赖的M2样巨噬细胞极化减轻LPS诱导的ALI,突出了其作为ALI治疗剂的潜力。这些发现为PNS的抗炎作用提供了机制见解,并强调了STAT6信号在其保护作用中的重要性。